Medicus Pharma Ltd. (MDCX) Stock

Healthcare · Drug Manufacturers - General · Member of Other US Stocks

Medicus Pharma Ltd. (MDCX) closed at USD 3.12 on 2026-10-14, a change of -97.4 % over the past year, with a market capitalization of USD 4.92M.

Medicus Pharma Ltd. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Medicus Pharma Ltd. key figures

Previous close

USD 3.12 (2026-10-14)

1-year change

-97.4 %

Market cap

USD 4.92M

Enterprise value

USD 10.84M

P/E ratio (trailing)

-0.03

P/E ratio (forward)

-0.14

EPS (trailing)

-123.69

EPS (forward)

-24.00

PEG ratio

n/a

Price to book

-2.34

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.38

Employees

16

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Medicus Pharma Ltd.

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Medicus Pharma Ltd. and compare it with other stocks.